Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Current assets:
Cash, cash equivalents and restricted cash	$ 813,817	$ 642,095
Short-term investments	69,121	236,882
Accounts receivable, net of allowance of $7,252 and $6,481 at March 31, 2024 and December 31, 2023, respectively	288,748	278,289
Inventory	43,024	40,759
Prepaid expenses and other current assets, net	46,734	60,524
Total current assets	1,261,444	1,258,549
Property and equipment, net	125,791	111,210
Operating lease right-of-use assets	54,553	56,537
Other assets	26,417	15,403
Total assets	1,468,205	1,441,699
Current liabilities:
Accounts payable	26,038	14,998
Accrued compensation	39,577	45,857
Other accrued liabilities	142,228	149,405
Deferred revenue, current portion	17,705	16,612
Short-term debt financing	80,401	80,402
Total current liabilities	305,949	307,274
Long-term debt financing	283,273	282,945
Deferred revenue, long-term portion and other liabilities	20,712	19,128
Operating lease liabilities, long-term portion	64,160	67,025
Total liabilities	674,094	676,372
Commitments and contingencies (Note 8)
Stockholders' equity:
Common stock, $0.0001 par value: 750,000 shares authorized at both March 31, 2024 and December 31, 2023; 122,234 and 119,581 shares issued and outstanding at March 31, 2024 and December 31, 2023, respectively	12	11
Additional paid-in capital	3,241,326	3,145,837
Accumulated deficit	(2,445,035)	(2,377,436)
Accumulated other comprehensive loss	(2,192)	(3,085)
Total stockholders' equity	794,111	765,327
Total liabilities and stockholders' equity	$ 1,468,205	$ 1,441,699